Literature DB >> 2857418

Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.

S T Appleyard, M J Dunn, V Dubowitz, M L Rose.   

Abstract

The distribution of HLA ABC class I antigens in human skeletal muscle obtained by needle biopsy was investigated by means of a monoclonal antibody (W6/32) and an immunoperoxidase technique. Five samples from normal individuals and twenty-nine from patients with various neuromuscular disorders were examined. Normal muscle fibres and those from patients with congenital muscular dystrophy expressed little or no class I antigens, whereas muscle fibres of patients with myositis and various X-linked muscular dystrophies showed consistently strong expression. In other neuromuscular diseases expression was more variable. The presence of class I antigens on diseased muscle fibres may render them susceptible to cytotoxic T cells; these antigens may thus have an important role in the destruction of muscle fibres.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857418     DOI: 10.1016/s0140-6736(85)91384-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  35 in total

1.  Cutting Edge: Augmenting Muscle MHC Expression Enhances Systemic Pathogen Control at the Expense of T Cell Exhaustion.

Authors:  Angela D Pack; Rick L Tarleton
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Expression of major histocompatibility complex class I antigens in rat muscle cultures: the possible developmental role in myogenesis.

Authors:  H Honda; A Rostami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  X-linked vacuolated myopathy : TNF-alpha and IFN-gamma expression in muscle fibers with MHC class I on sarcolemma.

Authors:  K Rouger; J P Louboutin; M Villanova; Y Cherel; M Fardeau
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

5.  Localization of interferons and interleukin 2 in polymyositis and muscular dystrophy.

Authors:  D A Isenberg; D Rowe; M Shearer; D Novick; P C Beverley
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 6.  HLA, immune response and disease.

Authors:  N K Mehra; V Taneja
Journal:  Indian J Pediatr       Date:  1989 Mar-Apr       Impact factor: 1.967

7.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

8.  Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.

Authors:  Valerie Ferreira; Jaap Twisk; Karin Kwikkers; Eleonora Aronica; Diane Brisson; Julie Methot; Harald Petry; Daniel Gaudet
Journal:  Hum Gene Ther       Date:  2014-02-28       Impact factor: 5.695

9.  Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes.

Authors:  D Michaelis; N Goebels; R Hohlfeld
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 10.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.